1-19 of 19
Sham Mailankody, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal 18 f-FDG-PET-CT Analysis in Newly Diagnosed Multiple Myeloma (NDMM) Patients Following Carfilzomib, Lenalidomide, Dexamethasone Induction and Lenalidomide Maintenance (CRd-R)

Neha S Korde, MD, Dickran Kazandjian, MD, Mark Roschewski, MD, Sham Mailankody, MD, Malin Hultcrantz, MD, PhD, Constance M. Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Peter Choyke, MD, Hani Hassoun, MD, Alexander M. Lesokhin, MD, Nikoletta Lendvai, MDPhD, Eric L. Smith, MD PhD, Ola Landgren, MDPhD, Karen A. Kurdziel, MD, Maria Liza Lindenberg, MD
Journal: Blood
Blood (2016) 128 (22): 3274.
https://doi.org/10.1182/blood.V128.22.3274.3274
Published: 2016
Journal Articles

Sustained High Rates of Complete Response and Minimal Residual Disease Negativity after 8 Cycles of Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (DEX) Followed By 2 Years of Lenalidomide Maintenance (CRd-R) in Patients with High-Risk Smoldering Multiple Myeloma: Updated Results of Clinical and Correlative Phase 2 Study

Dickran Kazandjian, MD, Neha S Korde, MD, Mark Roschewski, MD, Sham Mailankody, MD, Candis Morrison, RN, PhD, Elisabet E. Manasanch, MD, Mary L Kwok, MD, Nishant Tageja, MD, Manisha Bhutani, MD, Adriana Zingone, PhD, Rene Costello, Yong Zhang, PhD, Marcia Mulquin, Liz Lamping, Ashley Carpenter, Brenda Roberson, Irina Maric, MD, Katherine R. Calvo, MD PhD, Raul C Braylan, MD, Constance M. Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Diane C. Arthur, MD, Liza Lindenberg, Karen A. Kurdziel, MD, Peter Choyke, Seth M. Steinberg, PhD, William Figg, Wyndham H. Wilson, MD PhD, Ola Landgren, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3339.
https://doi.org/10.1182/blood.V128.22.3339.3339
Published: 2016
Journal Articles

Dietary Pattern and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Marianna Thordardottir, Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Johanna E Torfadottir, PhD, Bryndis E Birgisdottir, PhD, Debra Burton, Laufey Steingrimsdottir, PhD, Neha S Korde, MD, Sham Mailankody, MD, Gudny Eiriksdottir, Lenore J Launer, PhD, Tamara B Harris, MD, Ola Landgren, MDPhD, Vilmundur Gudnason, MDPhD, Sigurdur Y Kristinsson, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3257.
https://doi.org/10.1182/blood.V128.22.3257.3257
Published: 2016
Journal Articles

Comparison of Standard Assays (Serum Immunofixation and Protein Electrophoresis) with Hevylite Assay in Patients with Multiple Myeloma

Hani Hassoun, MD, Rosalynn Ruiz, BS, Murata Kazunori, PhD, Kathleen Azzi, Sean Devlin, PhD, Brittany Cooper, BS, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alexander M. Lesokhin, MD, David J Chung, MD PhD, Sham Mailankody, MD, Neha S Korde, MD, Sergio A. Giralt, MD, Ola Landgren, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5626.
https://doi.org/10.1182/blood.V128.22.5626.5626
Published: 2016
Journal Articles

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MD, Magnus Björkholm, MD, PhD, Gudny Eiriksdottir, Leonore J Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Vilmundur Gudnason, MD PhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 5650.
https://doi.org/10.1182/blood.V128.22.5650.5650
Published: 2016
Journal Articles

Immunophenotypic Evidence for Reactive Polyclonal Marrow Plasmacytosis in Multiple Myeloma Patients Receiving Long-Term Lenalidomide Therapy

Hani Hassoun, MD, Mikhail Roshal, MD PhD, Joshua Sabari, MD, Brittany Cooper, BS, James Nguyen, BS, Rosalyn Ruiz, BS, Qi Gao, Heather Landau, MD, Nikoletta Lendvai, MD PhD, David J. Chung, MD PhD, Alexander M. Lesokhin, MD, Neha S Korde, MD, Sham Mailankody, MD, Sergio A. Giralt, MD, Ola Landgren, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5605.
https://doi.org/10.1182/blood.V128.22.5605.5605
Published: 2016
Journal Articles

Whole Exome Sequencing from Nine Independent Sites of Extraosseous Disease in a Single Patient with Relapsed Multiple Myeloma Show That Extramedullary Disease Arise through a Combination of Branched and Parallel Evolution

Heather Landau, MD, Jun Fan, Sergio A. Giralt, MD, Jonathan U. Peled, MD PhD, Hani Hassoun, MD, Alexander M. Lesokhin, MD, Nikoletta Lendvai, MD PhD, Neha S Korde, MD, Sham Mailankody, MD, David J. Chung, MD PhD, Guenther Koehne, MD PhD, Eric L. Smith, MD PhD, Elli Papaemmanuil, PhD, Ola Landgren, MD PhD, Christine Iacobuzio-Donahue
Journal: Blood
Blood (2016) 128 (22): 2090.
https://doi.org/10.1182/blood.V128.22.2090.2090
Published: 2016
Journal Articles

Sustained Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (DEX) Followed By 2 Years of Lenalidomide Maintenance (CRd-R): Updated Results of a Phase 2 Study

Dickran Kazandjian, MD, Neha S Korde, MD, Mark Roschewski, MD, Sham Mailankody, MD, Candis Morrison, RN, PhD, Elisabet E. Manasanch, MD, Mary L Kwok, MD, Nishant Tageja, MD, Manisha Bhutani, MD, Adriana Zingone, PhD, Rene Costello, Yong Zhang, PhD, Marcia Mulquin, Liz Lamping, Ashley Carpenter, Brenda Roberson, Irina Maric, MD, Katherine R. Calvo, MD PhD, Raul C Braylan, MD, Constance M. Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Diane C. Arthur, MD, Liza Lindenberg, Karen A. Kurdziel, MD, Peter Choyke, Seth M. Steinberg, PhD, William Figg, Wyndham H. Wilson, MD PhD, Ola Landgren, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4527.
https://doi.org/10.1182/blood.V128.22.4527.4527
Published: 2016
Journal Articles

Minimal Residual Disease (MRD) Testing in Newly Diagnosed Multiple myeloma (MM) Patients: A Prospective Head-to-Head Assessment of Cell-Based, Molecular, and Molecular-Imaging Modalities

Neha Korde, MD, Sham Mailankody, MD, Mark Roschewski, MD, Malek Faham, Chitra Kotwaliwale, Martin Moorhead, PhD, Mary L Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, MD, Rene Costello, Yong Zhang, MD PhD, Adriana Zingone, MD PhD, Debbie Burton, Marcia Mulquin, RN, Ashley Carpenter, RN, Diamond Zuchlinski, RN, Elizabeth Lamping, George Carter, PA, Candis Morrison, Karen Kurdziel, MD, Maria Lindenberg, MD, Roger Kurlander, MD, Irina Maric, MD, Katherine R. Calvo, MD, PhD, Raul C Braylan, MD, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Diane C Arthur, MD, Seth M. Steinberg, PhD, William D Figg, PharmD, Peter Choyke, MD, Ola Landgren, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2105.
https://doi.org/10.1182/blood.V124.21.2105.2105
Published: 2014
Journal Articles

Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Final Results from the NCI Phase 2 Pilot Study

Ola Landgren, MD PhD, Mark Roschewski, MD, Sham Mailankody, MD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, MD, Adriana Zingone, MD PhD, Rene Costello, Debra Burton, Yong Zhang, MD PhD, Peter Wu, George Carter, PA, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Ashley Carpenter, RN, Verena Gounden, MD, Candice Morrison, NP, Irina Maric, MD, Katherine R. Calvo, MD, PhD, Raul C. Braylan, MD, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Diane C Arthur, MD, Liza Lindenberg, MD, Kurdziel Karen, MD, Peter Choyke, MD, Seth M. Steinberg, PhD, William D Figg, PharmD, Neha Korde, MD
Journal: Blood
Blood (2014) 124 (21): 4746.
https://doi.org/10.1182/blood.V124.21.4746.4746
Published: 2014
Journal Articles

Series of Hairy Cell Leukemia Patients with Co-Existent Plasma Cell Disorders

Neha Korde, MD, Sham Mailankody, MD, Evgeny Arons, PhD, Raul C. Braylan, MD, Mark Raffeld, MD, Elizabeth Maestri, RN, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Ola Landgren, MD PhD, Irina Maric, MD, Robert J. Kreitman, MD
Journal: Blood
Blood (2014) 124 (21): 5647.
https://doi.org/10.1182/blood.V124.21.5647.5647
Published: 2014
Journal Articles

Obesity and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Marianna Thordardottir, PhDstudent, Sigrun Helga Lund, PhD, Ebba K Lindqvist, MD PhDStudent, Rene Costello, Debra Burton, Neha Korde, MD, Sham Mailankody, MD, Gudny Eiriksdottir, Lenore J Launer, PhD, Vilmundur Gudnason, MD PhD, Tamara B Harris, MD MS, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 5706.
https://doi.org/10.1182/blood.V124.21.5706.5706
Published: 2014
Journal Articles

Biomarker Proteasome Levels Predict Response to Combination Therapy with Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients

Neha Korde, MD, Talib Dosani, Olga Simakova, PhD, Sham Mailankody, MD, Rene Costello, Mark Roschewski, MD, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, William D Figg, PharmD, Ola Landgren, MD PhD, Irina Maric, MD
Journal: Blood
Blood (2014) 124 (21): 2080.
https://doi.org/10.1182/blood.V124.21.2080.2080
Published: 2014
Journal Articles

Evaluation Of Circulating Cell-Free VDJ DNA As a Marker For Monitoring Patients With Multiple Myeloma (MM) During Treatment With Carfilzomib, Lenalidomide and Dexamethasone,

Roger Kurlander, MD, Yixin LI, Ph.D., Maryalice Stetler-Stevenson, MD, PhD, Constance Yuan, MD, PhD, Neha Korde, MD, Sham Mailankody, MD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, MD, Rene Costello, Yong Zhang, PhD, Adriana Zingone, MD, PhD, Peter Wu, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, Mark Roschewski, MD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1868.
https://doi.org/10.1182/blood.V122.21.1868.1868
Published: 2013
Journal Articles

Clinical and Correlative Pilot Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRd – R) In High Risk Smoldering Multiple Myeloma Patients

Ola Landgren, MD, PhD, Sham Mailankody, MD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, MD, Adriana Zingone, MD, PhD, Rene Costello, Debra Burton, Yong Zhang, PhD, Peter Wu, George Carter, PA, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, M.D., Liza Lindenberg, MD, Karen Kurdziel, MD, Peter Choyke, MD, Seth M. Steinberg, PhD, Mark Roschewski, MD, Neha Korde, MD
Journal: Blood
Blood (2013) 122 (21): 1939.
https://doi.org/10.1182/blood.V122.21.1939.1939
Published: 2013
Journal Articles

Multiple Myeloma Patients With Prior Knowledge Of MGUS Have a Better Survival Compared To Multiple Myeloma Patients Without Prior Knowledge Of MGUS

Elin Edda Sigurdardottir, Ingemar Turesson, MD, PhD, Sigrun Helga Lund, Ebba K Lindqvist, MD, PhD Student, Neha Korde, MD, Sham Mailankody, MD, Magnus Björkholm, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1984.
https://doi.org/10.1182/blood.V122.21.1984.1984
Published: 2013
Journal Articles

Minimal Residual Disease (MRD) Detection By Deep Sequencing In Newly Diagnosed Multiple Myeloma Patients Treated With Carfilzomib, Lenalidomide and Dexamethasone

Sham Mailankody, MD, Neha Korde, MD, Malek Faham, MD, PhD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, Li Weng, PhD, Martin Moorhead, PhD, Rene Costello, Yong Zhang, PhD, Adriana Zingone, MD, PhD, Debbie Burton, Peter Wu, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Roger Kurlander, MD, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, M.D., Mark Roschewski, MD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1902.
https://doi.org/10.1182/blood.V122.21.1902.1902
Published: 2013
Journal Articles

Phase II Clinical and Correlative Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRD-R) Induces High Rates Of MRD Negativity In Newly Diagnosed Multiple Myeloma (MM) Patients

Neha Korde, MD, Adriana Zingone, MD, PhD, Mary L Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, MD, Sham Mailankody, MD, Rene Costello, Yong Zhang, PhD, Debra Burton, George Carter, PA, Peter Wu, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, Mark Roschewski, MD, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, M.D., Liza Lindenberg, MD, Karen Kurdziel, MD, Pete Choyke, MD, Seth M. Steinberg, PhD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 538.
https://doi.org/10.1182/blood.V122.21.538.538
Published: 2013
Journal Articles

Serum Heavy-Light Chains (HLC) and Free Light Chains (FLC) As Predictors For Early CR In Newly Diagnosed Myeloma Patients Treated With Carfilzomib, Lenalidomide, and Dexamethasone (CRd)

Manisha Bhutani, MD, Rene Costello, Neha Korde, MD, Elisabet E. Manasanch, MD, Mary Kwok, MD, Nishant Tageja, MD, Sham Mailankody, MD, Dickran Kazandjian, MD, Peter Wu, Adriana Zingone, MD, PhD, Debra Burton, George Carter, PA, Diamond Zuchlinski, RN, Marcia Mulquin, RN, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Seth M. Steinberg, PhD, Mark Roschewski, MD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 762.
https://doi.org/10.1182/blood.V122.21.762.762
Published: 2013